T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes

MLA

Devillier, R., et al. “T-Replete Haploidentical Allogeneic Transplantation Using Post-Transplantation Cyclophosphamide in Advanced AML and Myelodysplastic Syndromes.” Bone Marrow Transplantation, vol. 51, no. 2, Feb. 2016, pp. 194–98. EBSCOhost, https://doi.org/10.1038/bmt.2015.270.

APA

Devillier, R., Bramanti, S., Fürst, S., Sarina, B., El-Cheikh, J., Crocchiolo, R., Granata, A., Chabannon, C., Morabito, L., Harbi, S., Faucher, C., Santoro, A., Weiller, P.-J., Vey, N., Carlo-Stella, C., Castagna, L., & Blaise, D. (2016). T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes. Bone Marrow Transplantation, 51(2), 194–198. https://doi.org/10.1038/bmt.2015.270

Chicago

Devillier, R, S Bramanti, S Fürst, B Sarina, J El-Cheikh, R Crocchiolo, A Granata, et al. 2016. “T-Replete Haploidentical Allogeneic Transplantation Using Post-Transplantation Cyclophosphamide in Advanced AML and Myelodysplastic Syndromes.” Bone Marrow Transplantation 51 (2): 194–98. doi:10.1038/bmt.2015.270.